IceCure Medical Ltd
ICCM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 61.9% | -27.6% | -17.1% | – |
| Cost of Goods Sold | $1 | $0 | $1 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 32.6% | 25% | 30.1% | 47.7% |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $1 | $3 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $1 | -$1 | $1 | $2 |
| Other Operating Expenses | $14 | $0 | $0 | $0 |
| Operating Expenses | $18 | $4 | $4 | $5 |
| Operating Income | -$18 | -$3 | -$4 | -$5 |
| % Margin | -2,108.2% | -644.8% | -504.4% | -517.1% |
| Other Income/Exp. Net | $14 | $0 | $0 | $0 |
| Pre-Tax Income | -$4 | -$3 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$3 | -$4 | -$4 |
| % Margin | -454% | -640.8% | -494.9% | -511.9% |
| EPS | -0.059 | -0.057 | -0.062 | -0.081 |
| % Growth | -3% | 7.9% | 22.8% | – |
| EPS Diluted | -0.06 | -0.057 | -0.062 | -0.081 |
| Weighted Avg Shares Out | 64 | 59 | 58 | 56 |
| Weighted Avg Shares Out Dil | 65 | 59 | 58 | 56 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$3 | -$4 | -$4 |
| % Margin | -442.7% | -633% | -492.1% | -507.8% |